The Impact of Reporting a Prior Penicillin Allergy on the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia.
Kimberly G BlumenthalErica S ShenoyMingshu HuangJames L KuhlenWinston A WareRobert A ParkerRochelle P WalenskyPublished in: PloS one (2016)
Nearly 25% of patients with MSSA bacteremia did not receive OT trial and about 10% did not receive AT completion. Reported penicillin allergy reduced, and ID consult increased, the likelihood of OT. Allergy evaluation, coupled with ID consultation, may improve outcomes in MSSA bacteremic patients.
Keyphrases
- staphylococcus aureus
- end stage renal disease
- atopic dermatitis
- ejection fraction
- newly diagnosed
- chronic kidney disease
- clinical trial
- infectious diseases
- study protocol
- palliative care
- methicillin resistant staphylococcus aureus
- randomized controlled trial
- patient reported outcomes
- biofilm formation
- metabolic syndrome
- emergency department
- escherichia coli
- phase iii
- adverse drug
- open label
- replacement therapy
- double blind